Adhera Therapeutics, Inc. (OTCMKTS:ATRX) Short Interest Update

Adhera Therapeutics, Inc. (OTCMKTS:ATRXGet Rating) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 16,100 shares, a drop of 21.5% from the June 30th total of 20,500 shares. Based on an average trading volume of 28,100 shares, the days-to-cover ratio is presently 0.6 days.

Adhera Therapeutics Stock Performance

Shares of ATRX opened at $0.07 on Tuesday. Adhera Therapeutics has a 12 month low of $0.04 and a 12 month high of $0.28. The stock’s 50-day moving average is $0.07 and its two-hundred day moving average is $0.07.

Adhera Therapeutics (OTCMKTS:ATRXGet Rating) last announced its quarterly earnings data on Monday, May 16th. The company reported ($0.03) earnings per share for the quarter.

About Adhera Therapeutics

(Get Rating)

Adhera Therapeutics, Inc focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc and changed its name to Adhera Therapeutics, Inc in October 2018. Adhera Therapeutics, Inc is based in Baton Rouge, Louisiana.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for Adhera Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adhera Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.